Correlation Between BioAffinity Technologies, and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Elicio Therapeutics, you can compare the effects of market volatilities on BioAffinity Technologies, and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Elicio Therapeutics.

Diversification Opportunities for BioAffinity Technologies, and Elicio Therapeutics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BioAffinity and Elicio is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between BioAffinity Technologies, and Elicio Therapeutics

Given the investment horizon of 90 days bioAffinity Technologies, is expected to under-perform the Elicio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, bioAffinity Technologies, is 1.04 times less risky than Elicio Therapeutics. The stock trades about -0.47 of its potential returns per unit of risk. The Elicio Therapeutics is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  503.00  in Elicio Therapeutics on October 24, 2024 and sell it today you would earn a total of  122.00  from holding Elicio Therapeutics or generate 24.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy94.74%
ValuesDaily Returns

bioAffinity Technologies,  vs.  Elicio Therapeutics

 Performance 
       Timeline  
bioAffinity Technologies, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days bioAffinity Technologies, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Elicio Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

BioAffinity Technologies, and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioAffinity Technologies, and Elicio Therapeutics

The main advantage of trading using opposite BioAffinity Technologies, and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind bioAffinity Technologies, and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges